{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:17:34Z","timestamp":1793128654184,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100003927","name":"Luke and Rachel Batten Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100003927","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH)","doi-asserted-by":"crossref","award":["R01 NS044310"],"award-info":[{"award-number":["R01 NS044310"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health (NIH)","doi-asserted-by":"crossref","award":["R21 NS067147"],"award-info":[{"award-number":["R21 NS067147"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.neuropharm.2012.05.040","type":"journal-article","created":{"date-parts":[[2012,6,6]],"date-time":"2012-06-06T09:06:02Z","timestamp":1338973562000},"page":"769-775","source":"Crossref","is-referenced-by-count":42,"title":["Age-dependent therapeutic effect of memantine in a mouse model of juvenile Batten disease"],"prefix":"10.1016","volume":"63","author":[{"given":"Attila D.","family":"Kov\u00e1cs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Saje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Ramji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2012.05.040_bib1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.nbd.2007.06.012","article-title":"Palmitoyl protein thioesterase 1 (Ppt1)-deficient mouse neurons show alterations in cholesterol metabolism and calcium homeostasis prior to synaptic dysfunction","volume":"28","author":"Ahtiainen","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib2","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1002\/jnr.21416","article-title":"Progressive oxidative damage in the central nervous system of a murine model for juvenile Batten disease","volume":"85","author":"Benedict","year":"2007","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s00213-007-0987-5","article-title":"Improvement of contextual memory by S 24795 in aged mice: comparison with memantine","volume":"196","author":"Beracochea","year":"2008","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.neuropharm.2012.05.040_bib4","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.nbd.2004.02.010","article-title":"Regional and cellular neuropathology in the palmitoyl protein thioesterase-1 null mutant mouse model of infantile neuronal ceroid lipofuscinosis","volume":"16","author":"Bible","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib5","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/pmic.200500412","article-title":"Alteration of the glutamate and GABA transporters in the hippocampus of the Niemann-Pick disease, type C mouse using proteomic analysis","volume":"6","author":"Byun","year":"2006","journal-title":"Proteomics"},{"key":"10.1016\/j.neuropharm.2012.05.040_bib6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2990.2008.00984.x","article-title":"Altered arginine metabolism in the central nervous system (CNS) of the Cln3-\/- mouse model of juvenile Batten disease","volume":"35","author":"Chan","year":"2009","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib7","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1460-9568.2007.05732.x","article-title":"Sphingosylphosphocholine effects on cultured astrocytes reveal mechanisms potentially involved in neurotoxicity in Niemann-Pick type A disease","volume":"26","author":"Chiulli","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib8","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s10545-011-9421-6","article-title":"Females experience a more severe disease course in batten disease","volume":"35","author":"Cialone","year":"2012","journal-title":"J.\u00a0Inherit. Metab. Dis."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib9","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/0092-8674(95)90274-0","article-title":"Isolation of a novel gene underlying Batten disease, CLN3","volume":"82","author":"Consortium","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2012.05.040_bib10","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1038\/sj.npp.1301535","article-title":"Acute injections of the NMDA receptor antagonist memantine rescue performance deficits of the Ts65Dn mouse model of Down syndrome on a fear conditioning test","volume":"33","author":"Costa","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.05.040_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.brainres.2011.04.020","article-title":"Glutamatergic neurotransmission in a mouse model of Niemann-Pick type C disease","volume":"1396","author":"D' Arcangelo","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/jnen\/62.2.127","article-title":"Inflammatory mechanisms after ischemia and stroke","volume":"62","author":"Danton","year":"2003","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib13","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1582-4934.2008.00314.x","article-title":"Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease","volume":"12","author":"Farfara","year":"2008","journal-title":"J.\u00a0Cell Mol. Med."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib14","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/jnr.22763","article-title":"Altered glutamate receptor function in the cerebellum of the Ppt1(-\/-) mouse, a murine model of infantile neuronal ceroid lipofuscinosis","volume":"90","author":"Finn","year":"2012","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00018-010-0468-6","article-title":"Interactions of the proteins of neuronal ceroid lipofuscinosis: clues to function","volume":"68","author":"Getty","year":"2011","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib16","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/sj.bjp.0707362","article-title":"Neuroprotective and anticonvulsant effects of EGIS-8332, a non-competitive AMPA receptor antagonist, in a range of animal models","volume":"152","author":"Gigler","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1750-3639.2004.tb00499.x","article-title":"Current state of clinical and morphological features in human NCL","volume":"14","author":"Goebel","year":"2004","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib18","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1177\/088307389501000602","article-title":"The neuronal ceroid-lipofuscinoses","volume":"10","author":"Goebel","year":"1995","journal-title":"J.\u00a0Child. Neurol."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib19","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1523\/JNEUROSCI.5473-08.2009","article-title":"Differential susceptibility to excitotoxic stress in YAC128 mouse models of Huntington disease between initiation and progression of disease","volume":"29","author":"Graham","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib20","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1073\/pnas.0712390105","article-title":"Protection from fatal viral encephalomyelitis: AMPA receptor antagonists have a direct effect on the inflammatory response to infection","volume":"105","author":"Greene","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib21","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1365-2818.1987.tb02837.x","article-title":"The efficiency of systematic sampling in stereology and its prediction","volume":"147","author":"Gundersen","year":"1987","journal-title":"J.\u00a0Microsc."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib22","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.bbamcr.2008.11.004","article-title":"Neuronal ceroid lipofuscinoses","volume":"1793","author":"Jalanko","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.neuropharm.2012.05.040_bib23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1078\/0940-2993-00301","article-title":"Behavioral phenotyping of mice in pharmacological and toxicological research","volume":"55","author":"Karl","year":"2003","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib24","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.nbd.2006.09.001","article-title":"Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis","volume":"25","author":"Kielar","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib25","doi-asserted-by":"crossref","first-page":"21673","DOI":"10.1074\/jbc.274.31.21673","article-title":"Elevation of intracellular glucosylceramide levels results in an increase in endoplasmic reticulum density and in functional calcium stores in cultured neurons","volume":"274","author":"Korkotian","year":"1999","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib26","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.expneurol.2007.09.012","article-title":"Attenuation of AMPA receptor activity improves motor skills in a mouse model of juvenile Batten disease","volume":"209","author":"Kovacs","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib27","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.nbd.2005.12.018","article-title":"Selectively increased sensitivity of cerebellar granule cells to AMPA receptor-mediated excitotoxicity in a mouse model of Batten disease","volume":"22","author":"Kovacs","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.neuropharm.2010.10.010","article-title":"Temporary inhibition of AMPA receptors induces a prolonged improvement of motor performance in a mouse model of juvenile Batten disease","volume":"60","author":"Kovacs","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.05.040_bib29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.nbd.2006.09.005","article-title":"IgG entry and deposition are components of the neuroimmune response in Batten disease","volume":"25","author":"Lim","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib30","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2174\/138945007780618472","article-title":"Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation","volume":"8","author":"Lipton","year":"2007","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.neuropharm.2012.05.040_bib31","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.expneurol.2009.01.022","article-title":"Cerebellar pathology and motor deficits in the palmitoyl protein thioesterase 1-deficient mouse","volume":"217","author":"Macauley","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/hipo.20367","article-title":"A\u00a0single application of MK801 causes symptoms of acute psychosis, deficits in spatial memory, and impairment of synaptic plasticity in rats","volume":"18","author":"Manahan-Vaughan","year":"2008","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2012.05.040_bib33","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2010.01.008","article-title":"Early increase in extrasynaptic NMDA receptor signaling and expression contributes to phenotype onset in Huntington's disease mice","volume":"65","author":"Milnerwood","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.05.040_bib34","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.neuropharm.2008.02.014","article-title":"Cognition-enhancing and anxiolytic effects of memantine","volume":"54","author":"Minkeviciene","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.05.040_bib35","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1006\/nbdi.1999.0267","article-title":"Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected]","volume":"6","author":"Mitchison","year":"1999","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib36","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0028-3908(99)00019-2","article-title":"Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist\u2013a review of preclinical data","volume":"38","author":"Parsons","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2012.05.040_bib37","series-title":"The Mouse Brain in Stereotaxic Coordinates","author":"Paxinos","year":"2001"},{"key":"10.1016\/j.neuropharm.2012.05.040_bib38","doi-asserted-by":"crossref","first-page":"42508","DOI":"10.1074\/jbc.M507380200","article-title":"High resolution 1H NMR-based metabolomics indicates a neurotransmitter cycling deficit in cerebral tissue from a mouse model of Batten disease","volume":"280","author":"Pears","year":"2005","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib39","doi-asserted-by":"crossref","first-page":"3494","DOI":"10.1002\/jnr.21343","article-title":"Metabolomic investigation of CLN6 neuronal ceroid lipofuscinosis in affected South Hampshire sheep","volume":"85","author":"Pears","year":"2007","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib40","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.brainres.2004.07.030","article-title":"Late onset neurodegeneration in the Cln3-\/- mouse model of juvenile neuronal ceroid lipofuscinosis is preceded by low level glial activation","volume":"1023","author":"Pontikis","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2174\/157015908783769671","article-title":"Pharmacodynamics of memantine: an update","volume":"6","author":"Rammes","year":"2008","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib42","first-page":"1373","article-title":"MR imaging and localized proton MR spectroscopy in late infantile neuronal ceroid lipofuscinosis","volume":"19","author":"Seitz","year":"1998","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib43","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/jnr.20123","article-title":"High-resolution magic angle spinning and 1H magnetic resonance spectroscopy reveal significantly altered neuronal metabolite profiles in CLN1 but not in CLN3","volume":"77","author":"Sitter","year":"2004","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib44","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s11481-008-9142-2","article-title":"Imaging microglial activation during neuroinflammation and Alzheimer's disease","volume":"4","author":"Venneti","year":"2009","journal-title":"J.\u00a0Neuroimmune Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib45","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.nbd.2005.11.008","article-title":"Visual deficits in a mouse model of Batten disease are the result of optic nerve degeneration and loss of dorsal lateral geniculate thalamic neurons","volume":"22","author":"Weimer","year":"2006","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib46","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.brainres.2007.05.018","article-title":"Alterations in striatal dopamine catabolism precede loss of substantia nigra neurons in a mouse model of juvenile neuronal ceroid lipofuscinosis","volume":"1162","author":"Weimer","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib47","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.brainres.2009.02.009","article-title":"Cerebellar defects in a mouse model of juvenile neuronal ceroid lipofuscinosis","volume":"1266","author":"Weimer","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib48","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1111\/j.1460-9568.2007.05899.x","article-title":"Acute and long-term effects of MK-801 on direct cortical input evoked homosynaptic and heterosynaptic plasticity in the CA1 region of the female rat","volume":"26","author":"Wohrl","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib49","doi-asserted-by":"crossref","first-page":"11246","DOI":"10.1523\/JNEUROSCI.2488-10.2010","article-title":"Memantine preferentially blocks extrasynaptic over synaptic NMDA receptor currents in hippocampal autapses","volume":"30","author":"Xia","year":"2010","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib50","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S0006-8993(98)00449-1","article-title":"Neurochemical alterations in the cerebellum of a murine model of Niemann-Pick type C disease","volume":"799","author":"Yadid","year":"1998","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.05.040_bib51","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.pbb.2006.08.011","article-title":"Enhancement of long-term spatial memory in adult rats by the noncompetitive NMDA receptor antagonists, memantine and neramexane","volume":"85","author":"Zoladz","year":"2006","journal-title":"Pharmacol. Biochem. Behav."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812002481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812002481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,22]],"date-time":"2018-11-22T19:51:28Z","timestamp":1542916288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390812002481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0028390812002481"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2012.05.040","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}